Canada · Health Canada Drug Product Database

DIACOMP - CAP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
37506
DIN
02227169
Form
Capsule
Company as listed by source
ENZYMATIC THERAPY (CANADA) INC.
Source status
Cancelled Post Market (2007-07-27)
Source last updated
2025-03-22

Source-listed ingredients

  • D-ALPHA TOCOPHEROL — 25 UNIT
  • ASCORBIC ACID — 50 MG
  • PYRIDOXINE HYDROCHLORIDE — 5 MG
  • VITAMIN B12 — 125 MCG
  • BIOTIN — 500 MCG
  • MAGNESIUM (MAGNESIUM HVP CHELATE) — 50 MG
  • ZINC (ZINC GLUCONATE) — 2.5 MG
  • MANGANESE (MANGANESE HVP CHELATE) — 5 MG
  • CHROMIUM (CHROMIUM HVP CHELATE) — 25 MCG
  • SELENIUM (SELENIUM HVP CHELATE) — 20 MCG

These values do not establish equivalence or a dose recommendation.

Packages

  • 80

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →